CrushSCI.com
99.0平均天数
92.5中位天数
30最短天数
248最长天数
2652025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

148 天

Protocol of the randomized controlled trial of electronic Patient-Reported Outcome Monitoring with Integrated hospital–community pharmaciSt Engagement for diverse outpatient anticancer chemotherapy: the PRO-MISE trial

作者
Itsuki Osawa; Tohru Takebe; Shuhei Saito; Michiko Yamazaki; Tomoya Saika; Hideyuki Ohzawa; Shunsuke Yui; Hiroki Yamaguchi; Yasushi Imai; Takuhiro Yamaguchi; Shunya Ikeda展开收起
作者单位
1. Okinaka Memorial Institute for Medical Research, Tokyo, Japan; 2. KAKEHASHI Inc., Tokyo, Japan; 3. Department of Social Medical Sciences, Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan; 4. Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan; 5. Department of Clinical Oncology, Jichi Medical University, Tochigi, Japan; 6. Department of Hematology, Nippon Medical School, Tokyo, Japan; 7. Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan; 8. Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, Japan展开收起
PDF源文件 DOI 网页
87 天

Combined assessment of skeletal muscle mass and quality in allogeneic hematopoietic stem cell transplantation: a longitudinal study of physical function and complications

作者
Ryota Hamada; Masanobu Murao; Junsuke Miyasaka; Michiko Matsushita; Ayumi Otagaki; Tsugumi Asano; Junya Kanda; Yasuyuki Arai; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Akira Tamaki展开收起
作者单位
1. Rehabilitation Unit, Kyoto University Hospital, Kyoto, Japan; 2. Graduate School of Rehabilitation Science, Hyogo Medical University, Kobe, Japan; 3. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 4. Department of Cytotherapy, Kyoto University Hospital, Kyoto, Japan展开收起
PDF源文件 DOI 网页
80 天

Real-world surgical outcomes and prognostic factors in stage III–IVA laryngeal squamous cell carcinoma: a multicenter, retrospective, cohort study in northern Japan

作者
Akira Ohkoshi; Katsunori Katagiri; Satoshi Kano; Kazutake Yagi; Hiroshi Idogawa; Satoshi Toyoma; Iori Kusaka; Takashi Kasai; Yukiko Saito; Kizuku Owada; Hisataka Ominato; Haruka Kaya; Eiichi Ishida; Kazuya Kurakami; Atsushi Yoshimura; Kenta Taguchi; Takuya Yoshida; Ryo Ishii; Kenjiro Higashi; Yukio Katori展开收起
作者单位
1. Department of Otorhinolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan; 2. Department of Otolaryngology—Head and Neck Surgery, Iwate Medical University School of Medicine, Iwate Medical University, Morioka, Japan; 3. Department of Otolaryngology—Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan; 4. Department of Head and Neck Surgery, Miyagi Cancer Center, Natori, Japan; 5. Department of Otorhinolaryngology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; 6. Department of Otolaryngology, Fukushima Medical University, Fukushima, Japan; 7. Department of Otolaryngology—Head and Neck Surgery, Sapporo Medical University, Sapporo, Japan; 8. Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan; 9. Department of Otorhinolaryngology and Head and Neck Surgery, Akita University Graduate School of Medicine, Akita, Japan; 10. Department of Otorhinolaryngology—Head and Neck Surgery, National Sendai Medical Center, Sendai, Japan; 11. Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Yamagata University, Yamagata, Japan; 12. Department of Otolaryngology, Head and Neck Surgery, Hokkaido Cancer Center, Sapporo, Japan; 13. Department of Otorhinolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan展开收起
PDF源文件 DOI 网页
92 天

Patient-reported outcome sub-analysis of a phase 2 trial of bladder preservation therapy with atezolizumab and radiation therapy (BPT-ART) for invasive bladder cancer

作者
Bryan J. Mathis; Yoshiyuki Nagumo; Tomokazu Kimura; Hitoshi Ishikawa; Yuta Sekino; Kazushi Maruo; Yukio Kageyama; Hiroki Ushijima; Jun Kamei; Hideomi Yamashita; Haruhito Azuma; Keiji Nihei; Taku Naiki; Natsuo Tomita; Yasuyuki Kobayashi; Kotaro Yoshio; Takashi Matsumoto; Tadamasa Yoshitake; Takahiro Osawa; Kentaro Nishioka; Yuki Kita; Takashi Mizowaki; Toyonori Tsuzuki; Koichi Hashimoto; Hiroyuki Nishiyama展开收起
作者单位
1. Department of Cardiovascular Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; 2. Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; 3. Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 4. Department of Radiation Oncology, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; 5. Department of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; 6. Tsukuba Clinical Research & Development Organization, University of Tsukuba, Tsukuba, Japan; 7. Department of Urology, Saitama Cancer Center, Ina, Japan; 8. Department of Radiation Oncology, Saitama Cancer Center, Ina, Japan; 9. Department of Urology, The University of Tokyo, Bunkyo-ku, Japan; 10. Department of Radiation Oncology, The University of Tokyo, Bunkyo-ku, Japan; 11. Department of Urology, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan; 12. Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan; 13. Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; 14. Department of Radiology, Graduate School of Medical Sciences, Nagoya City University, Aichi, Japan; 15. Department of Urology, Okayama University Graduate School of Medicine, Okayama, Japan; 16. Department of Proton Beam Therapy, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan; 17. Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 18. Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 19. Department of Urology, Hokkaido University, Sapporo, Japan; 20. Department of Radiation Medical Science and Engineering, Faculty of Medicine, Hokkaido University, Hokkaido, Japan; 21. Department of Urology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan; 22. Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 23. Department of Surgical Pathology Department, Aichi Medical University, Nagakute, Japan; 24. Center for Cyber Medicine Research, University of Tsukuba, Tsukuba, Japan展开收起
PDF源文件 DOI 网页
97 天

Clinical benefit and economic value of fosnetupitant versus aprepitant in carboplatin-Based chemotherapy: a real-world study

作者
Hiroshi Inano; Yoshihito Morimoto; Atsushi Kawamura; Taichi Ikegami; Tomoki Niizuma; Kanata Kitagawa; Rie Usami; Kozue Nakagomi; Aiko Shono; Kazuhiro Watanabe; Katsuya Otori展开收起
作者单位
1. Department of Pharmacy, Kitasato University Hospital, Sagamihara, Japan; 2. Education and Research Center for Clinical Pharmacy, Showa Pharmaceutical University, Machida, Tokyo, Japan; 3. Laboratory of Public Health, Showa Pharmaceutical University, Machida, Tokyo, Japan; 4. Laboratory of Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University, Sagamihara, Japan展开收起
PDF源文件 DOI 网页
108 天

Preoperative predictors for the extent of facial nerve sacrifice in parotid gland cancer: an ordinal logistic regression and nomogram analysis

作者
Keishi Fujiwara; Satoshi Kano; Nayuta Tsushima; Hiroshi Idogawa; Hayato Imanari; Masaki Kakumu; Mai Sakai; Akihiro Homma展开收起
作者单位
1. Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan展开收起
PDF源文件 DOI 网页

FAQ

International Journal of Clinical Oncology审稿要多久?

截至2026-11-19,CrushSCI 收录了 International Journal of Clinical Oncology 的 20 篇完整审稿记录。最快一篇从收稿到录用用了 30 天(AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC,2026-06-14 收稿,2026-07-14 录用),最慢一篇用了 248 天;平均 99.0 天,中位数 92.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。